Synonyms: Example 26A [WO2014096388] | MEN1703 | SEL-24 | SEL24
Compound class:
Synthetic organic
Comment: The chemical structure for dapolsertib was obtained from proposed INN list 130 (Feb. 2024). This matched to clinical lead SEL-24 (MEN1703) via PubChem, and to compound 26A in patent WO2014096388 [1]. The compound is proposed as dual pan-PIM/FLT3 kinase inhibitor for the treatment of acute myeloid leukemia.
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
5,6-dibromo-4-nitro-2-piperidin-4-yl-1-propan-2-ylbenzimidazole |
International Nonproprietary Names | |
INN number | INN |
12910 | dapolsertib |
Synonyms |
Example 26A [WO2014096388] | MEN1703 | SEL-24 | SEL24 |
Database Links | |
CAS Registry No. | 1616359-00-2 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL4467168 |
GtoPdb PubChem SID | 491299986 |
PubChem CID | 76286825 |
Search Google for chemical match using the InChIKey | UOUBCIJIWDLRGM-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | UOUBCIJIWDLRGM |
Search PubMed clinical trials | dapolsertib |
Search PubMed titles | dapolsertib |
Search PubMed titles/abstracts | dapolsertib |
UniChem Compound Search for chemical match using the InChIKey | UOUBCIJIWDLRGM-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UOUBCIJIWDLRGM-UHFFFAOYSA-N |